Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62 (HNRNPA1P62)

Target
HNRNPA1P62
Molecular classification
Other (Pseudogene, non-coding RNA locus)
01

Overview

HNRNPA1P62, or Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62, is a pseudogene—meaning it is a non-functional copy of the active HNRNPA1 gene that encodes the hnRNP A1 protein[1]. Pseudogenes are DNA sequences derived from ancestral or active genes but usually accumulate mutations that prevent them from producing a functional protein[7]. While some pseudogenes have regulatory, epigenetic, or non-coding RNA roles in certain biological contexts (e.g., as competitive endogenous RNAs in cancer), there is no specific evidence that HNRNPA1P62 has direct biological or pathological significance. Unlike the parent HNRNPA1 gene/protein, HNRNPA1P62 does not participate in RNA binding, RNA splicing, or regulation of gene expression, nor is it a recognized drug target or biomarker[1][7]. If the intent is to study therapeutic targets in the hnRNP family, the protein-coding gene **HNRNPA1** (heterogeneous nuclear ribonucleoprotein A1) would be the canonical molecule of interest, distinct from this pseudogene.

Other names
hnRNP A1P62HNRNPA1P62
02

Mechanism of action

None currently described—for drugs, since it is not a functional protein target.

03

Biological functions

At present, there is no well-established function for HNRNPA1P62. By analogy with pseudogenes, some may exert regulatory effects via non-coding RNAs or acting as competitive endogenous RNAs, but this has not been specifically described for HNRNPA1P62
04

Disease associations

There is no documented involvement of HNRNPA1P62 in disease. Some pseudogenes are investigated as modulators in cancer or other conditions through epigenetic or RNA-mediated mechanisms, but HNRNPA1P62 has not been directly implicated
05

Safety considerations

None currently described, as this locus is not therapeutically targeted.
06

Interacting drugs

None currently described
07

Biomarkers

None currently described

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62 (HNRNPA1P62).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62 (HNRNPA1P62).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call